Biotech entity
Every one of those 1 sits in a single category, pharma. Bora Pharmaceuticals is most often covered alongside Insilico Medicine, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Bora Pharmaceuticals, all published on July 15, 2026.
Last mentioned: Jul 15, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Bora Pharmaceuticals is most often covered alongside Insilico Medicine, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Bora Pharmaceuticals, all published on July 15, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bora Pharmaceuticals. Shared-story counts are live from our verified record — not editorial picks.
The proposed alliance between AI powerhouse Insilico Medicine and CDMO Bora Pharmaceuticals could create a seamless pipeline from generative chemistry to commercial manufacturing. With a headline potential of over $2.5 billion, the deal targets multiple therapeutic programs and directly addresses the translational gap that often stalls promising drug candidates.
Source: prnewswire.com · prnewswire.com
Bora Pharmaceuticals is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
